Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
about
sameAs
Non steroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomasTherapeutic utility of aspirin in the ApcMin/+ murine model of colon carcinogenesis.Surface phospholipids in gastric injury and protection when a selective cyclooxygenase-2 inhibitor (Coxib) is used in combination with aspirinAspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.Cost-effectiveness of aspirin adjuvant therapy in early stage colorectal cancer in older patients.Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance?Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancerChemoprevention of colorectal cancer with nonsteroidal anti-inflammatory drugs.Chemoprevention of colorectal cancer: two steps forward, one step back?Patient preferences for the chemoprevention of colorectal cancer.Aspirin for primary prevention: do potential benefits outweigh the risks?The role of low-dose aspirin in the prevention of colorectal cancer.Potential cost-effectiveness of colorectal cancer chemoprevention with nonsteroidal anti-inflammatory drugs.Colon cancer: preventive agents and the present status of chemoprevention
P2860
Q24247367-8DFC5C50-5DC8-4FCF-A43D-685085AAF923Q24799697-9E01C825-B1B2-4690-A009-479CF540E4D7Q28219464-B8592180-1959-496D-AFF1-749F8DB5DDD0Q30457290-110D3273-5EF6-4EDD-897E-B6689C39C486Q34251380-DA1A53E1-0905-4ADB-8A33-19A3C1B694F9Q34275436-F659173C-9199-416E-8F94-5F4A7D404EF9Q34296467-3BA5F03F-051C-40B5-BF16-5070CBE240DCQ36367822-F7255499-212B-437B-AD0B-9C0277CECAB2Q36677468-CA7E3BF4-BD66-4B3B-83FA-B71526025C43Q37080424-0C077230-2E8D-4E45-A22E-39E070441423Q37542357-DCC3772D-3151-4791-B4C9-DEC534CB7EADQ37982139-7D9D4FEC-9827-478D-877B-13D27183C475Q43266418-A498366F-008C-4883-A7AE-9F4F8D76ADC5Q54172424-D9CED959-13C2-4598-B388-EF855E0AD9F6
P2860
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@ast
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@en
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@nl
type
label
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@ast
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@en
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@nl
prefLabel
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@ast
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@en
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@nl
P356
P1433
P1476
Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis
@en
P2093
Amnon Sonnenberg
Saud Suleiman
P356
10.1053/GAST.2002.29689
P407
P50
P577
2002-01-01T00:00:00Z